Last updated: 22 Jan 2023
10.21608/ejchem.2021.71477.3570
Benzimidazole, Heterocyclic, Substituted benzimidazole, Pharmacological activities, Rivoglitazone, Candesartan
Asma S.
Al-Wasidi
Department of Chemistry, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh 11671, Saudi Arabia
asalwasidi@pnu.edu.fa
Moamen S.
Refat
Department of Chemistry, Faculty of Science, Taif University, P.O. Box 888, Al-Hawiah, Taif 21974, Saudi Arabia,, Department of Chemistry, Faculty of Science, Port Said University, Port Said, Egypt
msrefat@yahoo.com
Ahmed M.
Naglah
Department of Pharmaceutical Chemistry, Drug Exploration & Development Chair (DEDC), College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia,, Peptide Chemistry Department, Chemical Industries Research Division, National Research Centre, 12622-Dokki, Cairo, Egypt
anaglah@ksu.edu.sa
Riyadh
0000-0003-4377-5239
Ahmed A.
Elhenawy
Chemistry Department, Faculty of Science, Al-Azhar University (Boys'Branch), Nasr City, Cairo, Egypt
aelhenawy@bu.edu.sa
64
5
23661
2021-05-01
2021-04-07
2021-05-01
2,631
2,646
0449-2285
2357-0245
https://ejchem.journals.ekb.eg/article_164696.html
https://ejchem.journals.ekb.eg/service?article_code=164696
39
Original Article
297
Journal
Egyptian Journal of Chemistry
https://ejchem.journals.ekb.eg/
Details
Type
Article
Created At
22 Jan 2023